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Abstract
Background: Expressed in embryonic development, matrix metalloprotein-9 (MMP-9) is absent
in most of developed adult tissues, but recurs in inflammation during tissue injury, wound healing,
tumor formation and metastasis. Expression of MMP-9 is tightly controlled by extracellular cues
including pro-inflammatory cytokines and extracellular matrix (ECM). While the pathologic
functions of MMP-9 are evident, the intracellular signaling pathways to control its expression are
not fully understood. In this study we investigated mechanism of cytokine induced MMP-9 with
particular emphasis on the role of p21-activated-kinase-1 (PAK1) and the down stream signaling.
Results: In response to TNF-alpha or IL-1alpha, PAK1 was promptly activated, as characterized by
a sequential phosphorylation, initiated at threonine-212 followed by at threonine-423 in the
activation loop of the kinase, in human skin keratinocytes, dermal fibroblasts, and rat hepatic
stellate cells. Ectopic expression of PAK1 variants, but not p38 MAP kinase, impaired the TNF-
alpha-induced MMP-9 expression, while other MMPs such as MMP-2, -3 and -14 were not affected.
Activation of Jun N-terminal kinase (JNK) and NF-kappaB has been demonstrated to be essential
for MMP-9 expression. Expression of inactive PAK1 variants impaired JNK but not NF-kappaB
activation, which consequently suppressed the 5'-promoter activities of the MMP-9 gene. After the
cytokine-induced phosphorylation, both ectopically expressed and endogenous PAK1 proteins
were promptly accumulated even in the condition of suppressing protein synthesis, suggesting the
PAK1 protein is stabilized upon TNF-alpha stimulation. Stabilization of PAK1 protein by TNF-alpha
treatment is independent of the kinase catalytic activity and p21 GTPase binding capacities. In
contrast to epithelial cells, mesenchymal cells require 3-dimensional type-I collagen in response to
TNF-alpha to massively express MMP-9. The collagen effect is mediated, in part, by boost JNK
activation in a way to cooperate the cytokine signaling.
Conclusion: We identified a novel mechanism for MMP-9 expression in response to injury signals,
which is mediated by PAK1 activation and stabilization leading JNK activation.
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Degradation of extracellular matrix (ECM), as mediated
by matrix metalloproteinases (MMPs) and antagonized
by tissue inhibitors of matrix metalloproteinases (TIMPs),
is critical for embryonic development and adult tissue
homeostasis [1,2]. Conversely, uncontrolled ECM degra-
dation occurs in many degenerative diseases [3,4]. For
instance, excessive presence of MMPs has been well docu-
mented in cancer dissemination, arthritis development,
and chronic wound progression [5]. Among the twenty-
some members of the MMP family in either the human or
murine genome the proteinases can be classified not only
based on their structural conservation, but also by the
means of their expression. Of our interest for many years
is the regulation of MMP-9, a type-IV collagenase in tissue
injury and repair. Not expressed in most of adult devel-
oped tissues, MMP-9 is promptly expressed in response to
tissue damages under the control of pro-inflammatory
cytokines [6,7]. Nascent proMMP-9 is maintained in
latency through interaction between a conserved cysteine
in the pro-peptide domain and a zinc atom in the catalytic
domain. Furthermore, TNF-α-induced maturation of
proMMP-9 by skin cells is mediated by down regulation
of TIMP-1, while the converting enzymes are seemingly
constitutively present [8]. Recently we uncovered alpha-1-
antichymotrypsin (alpha-ACT) as a novel pathological
inhibitor that directly antagonizes the proMMP-9 convert-
ing enzyme in skin tissues [9]. Thus, generation of active
MMP-9 within tissues is tightly monitored at the levels of
gene expression, protein processing, and antagonization
by inhibitors targeting at either proMMP-9 (by TIMP-1) or
converting enzyme (by alpha-ACT).
Innate immunity and its produced waves of inflammatory
cytokines are the initial signals to trigger expression of
MMPs in tissue injury phase. Compelling evidence of in
vitro experiments also demonstrates the critical roles of
inflammatory cytokines in control of MMP expression
and activation. Intracellular signals governing the expres-
sion of MMPs have been extensively studied; among
them, Jun N-terminal kinase (JNK) and nuclear factor
kappa B (NF-kB) signaling pathways are essential to
induce many MMPs [10,11]. Still outstanding is that how
other extracellular cue, such as ECM, in cooperation with
pro-inflammatory cytokines control MMP expression, of
which is particularly critical for mesenchymal cells. For
instance, in addition to TNF-α or IL-1, the 3-dimentional
type-I collagen is also required to maximally induce
MMP-9 by either human dermal fibrobaslts or rat hepatic
stellate cells [6,7].
p21-activatd kinase (PAK), a family of serine/threonine
kinases conserved from yeast to human, is important for
regulation of cytoskeleton, cell migration, and cell cycle
progression [12]. PAK1 was originally identified through
its binding to p21 GTPase [13,14]. Like many other pro-
tein kinases, PAK1 retains inactive by its own pseudo-sub-
strate like domain, and is activated by binding GTP-
charged proteins, which consequently leads conforma-
tional changes and auto-phosphorylation. Non-canoni-
cally, PAK1 can be phosphorylated and activated by PDK1
which phosphorylates a conserved threonine-423 within
the active loop [15]. In addition to regulating cytoskeletal
proteins, PAK1 also controls MAP kinases, such as JNK
and p38 MAP kinases [16,17]. Furthermore, PAK1 also
modulate NF-κB activity [18,19]. Although the dynamics
of cytoskeleton and the formation of stress filaments are
critical for cell-matrix interactions in inflammation, very
little is known if and how inflammatory cytokines regu-
late PAK1 in control of MMP expression.
In this study we demonstrated an unrecognized mecha-
nism by which TNF-α activates PAK1 by a sequential
phosphorylation from threonine-212 to threonine-423 in
human epithelial cells and fibroblasts. Similarly, IL-1α
also promotes PAK1 activation in rat hepatic stellate cells.
Moreover, TNF-α treatment promptly results in accumula-
tion of PAK1 protein, but not p38 MAP kinase, in part by
stabilization of the former. Although the details are
unknown to date, TNF-α-mediated stabilization of PAK1
is independent of its catalytic activity and p21 GTPase
binding capacities. Ectopic expression of PAK1 variants
impairs JNK but not NF-κB pathway, which in turn sup-
presses the promoter activation and transcription of
MMP-9. Expression of other MMPs such as MMP-2, MMP-
3, and MMP-14 as well as TIMP-1 is, in contrast, not
affected by PAK1. We also characterized the differences of
MMP-9 expression between human keratinocytes and der-
mal fibroblasts. For keratinocytes, TNF-α or IL-1 is suffi-
cient to induce MMP-9, while mesenchymal cells such as
dermal fibroblasts and hepatic stellate cells require type-I
collagen as an additional factor which boosts JNK activity
to maximally induce MMP-9.
Results
Cytokine-induced expression of MMP-9 by human skin is 
partially reconstituted by primary keratinocytes and 
dermal fibroblasts
First, we surveyed the expression pattern of gelatinases by
biopsies from patients with non-healed chronic (open
wounds for more than 30 days) or healed wounds, as well
as normal skin tissue. As shown in Fig. 1A, massive
amount of proMMP-9 (92-kDa) and mature form (82-
kDa) were evident in non-healed wounds, while minimal
level of the proteinase was found in healed and normal
skin tissues. Conversely, low level of proMMP-2 was
evenly expressed by all three skin samples, while mature
MMP-2 was found in both healed and non-healed skin.
Excessive expression of MMP-9 in non-healed skin is asso-
ciated with persistent inflammation in chronic wounds.Page 2 of 15
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BMC Immunology 2009, 10:15 http://www.biomedcentral.com/1471-2172/10/15To confirm the notion, isolated human dermal fibroblasts
at the early passages (p < 3) were cultured on plastic, or
embedded in 3-D type-I collagen. Cultured on plastic,
dermal fibroblasts expressed a minimal level of proMMP-
9 in response to TNF-α; under the combination of TNF-α
and TGF-β, the fibroblasts produced massive proMMP-9
(Fig. 1B). Only in 3D type-I collagen, the fibroblasts also
generated mature MMP-9 in response to the combination
of TNF-α and TGF-β. We also measured the steady state of
MMP-9 mRNA level. Dermal fibroblasts cultured on plas-
tic or in 3D collagen gel were exposed to TNF-α, TGF-β,
and their combination for 16 hrs, and the mRNA level of
MMP-9 was determined by real-time RT-PCR. As shown,
the mRNA gives almost identical ranking of expression as
to the protein levels, demonstrating that the regulation of
MMP-9 by TNF-α and collagen is mostly at the mRNA
Expression of MMP-9 by human skin of wounds is partially reconstituted by the skin cellsFigure 1
Expression of MMP-9 by human skin of wounds is partially reconstituted by the skin cells. (A) Gelatianses expres-
sion by human skin. Biopsies of normal skin, healed and non-healed wounds (full thickness, about 100 mg) were immersed in 1 
ml DMEM for 6-hrs and secreted gelatinases were examined by zymography. (B) Early passages of human dermal fibroblasts 
(HDFs) were cultured on either plastic or in 3D type-I collagen, and treated by cytokines. After 3 days the conditioned 
medium was examined for gelatinases. (C) The mRNA levels of MMP-9 from HDFs cultured on plastic or in 3D type-I collagen 
with or without cytokines for 16 hrs were analyzed by real-time RT-PCR. (D) Zymography of the conditioned medium from 
the primary human keratinocytes (HKC) cultured for 3 days.
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BMC Immunology 2009, 10:15 http://www.biomedcentral.com/1471-2172/10/15level (Fig. 1C). Thus, multiple extracellular cues including
combination of two drastic different cytokines, TNF-α and
TGF-β, and ECM render the dermal fibroblasts to generate
maximal level of MMP-9, implying a situation in inflam-
ing tissues.
Primary human keratinocytes produced minimal level of
proMMP-9 in response to TNF-α, and the expression was
also additionally enhanced in concert with TGF-β (Fig.
1D). Of note are two clear distinguished features between
the dermal fibroblasts and keratinocytes in terms of MMP-
9 expression. First, ECM has a profound role to induce
MMP-9 expression by dermal fibroblasts but not keratino-
cytes (data not shown). Second, MMP-2, a mesenchymal
MMP is largely absent in keratinocytes. Taken together,
both the keratinocytes and dermal fibroblasts of human
skin may contribute to the massive expression of MMP-9
under the stimulation of inflammatory cytokines in
inflammation.
PAK1 mediates TNF- -induced expression of MMP-9 but 
not MMP-2
To elucidate the intracellular signaling to govern MMP
expression we transduced human dermal fibroblasts with
lentivirus to express GFP, PAK1 wild type, PAK1 triple
mutant (kinase inactive and absence of p21GTPase bind-
ing), and PAK1 K299R mutant (kinase inactive) respec-
tively. The viral transduced dermal fibroblastic cell lines
were then embedded in type-I collagen, followed by TNF-
α stimulation at the indicated dose for 3 days. Gelatinases
in conditioned medium were resolved by zymography.
Strikingly, the expression of proMMP-9 induced by the
synergistic action of TNF-α and collagen was totally sup-
pressed by PAK1 variants, but not GFP which works as a
negative control (Fig. 2A). The specific effects of PAK1 on
MMP-9 expression were evident by the absence of regula-
tion on the expression of proMMP-2 as well as the matu-
ration of the zymogen (transition from 72-kDa to 62-
kDa). The wild-type PAK1 at the situation of over expres-
sion partially ablated MMP-9 expression, which may due
to blockage of signaling traffics under over-expression
(data not shown). Thereafter, we measured the steady
state of MMP-9 mRNA by the human fibroblasts express-
ing either GFP or PAK1 mutant (K299R) cultured on plas-
tic or in 3D type-I collagen. After 16 hr treatment by either
TNF-α or TGF-β, as well as their combination, the MMP-9
mRNA was determined by real-time RT-PCR. As shown in
Fig. 2B, induction of MMP-9 mRNA at all these conditions
was totally impaired by the kinase inactive PAK1. Finally,
we measured the effect of PAK1 on the 5'-promoter activ-
ity of the MMP-9 gene. The 5' promoter activities of MMP-
9 were measured by dual luciferase assay through transfec-
tion of dermal fibroblasts with a reporter plasmid express-
ing firefly luciferase driven by a 670-bp 5'-promoter of
MMP-9, while the control was monitored by renilla luci-
ferase driven by CMV promoter. As shown in Fig. 2C the
cytokine-induced activation of MMP-9 promoter was
impaired by the PAK1 mutant.
TNF- -induced stabilization of the ectopically expressed 
PAK1 protein
We then addressed the nature of TNF-α regulation of
PAK1. First, we analyzed the cell lines constitutively
expressing PAK1 driven the viral promoter. After 3 days of
TNF-α exposure the protein level of the ectopically
expressed PAK1 was unexpectedly elevated, indicating a
possible mechanism by which TNF-α signaling results in
stabilization of PAK1 protein (Fig. 2D). Importantly, the
TNF-α induced accumulation of PAK1 protein is inde-
pendent of the kinase activities and p21 GTPase binding,
as measured by the similar elevation of the variants of
K299R and the triple mutant in response to TNF-α. Meas-
urement at fine time points demonstrated again the
prompt mode of elevation of the ectopically expressed
PAK1 after TNF-α treatment (Fig. 2E). Because the ectopi-
cally expressed PAK1 is driven by constitutively active viral
promoter, the TNF-α induced elevation of the kinase is,
therefore, likely mediated by stabilization of the protein.
To strengthen the notion we treated the dermal fibroblasts
with cycloheximide to block protein synthesis and to
monitor the degradation of the kinase. Under 20 μg/ml of
cycloheximide, which sufficiently suppresses many pro-
tein syntheses, the PAK1 protein was still elevated under
TNF-α treatment, demonstrating that the cytokine-
dependent elevation of PAK1 is mediated by stabilization
(Fig. 2E).
Immortalized human keratinocytes (IKC) were also trans-
duced by the same set of lentiviruses, and the cells were
treated by cytokines for 3 days. As shown in Fig. 3A,
proMMP-9 was abundantly induced by IKC transduced by
the wild type PAK1 virus in response to TNF-α but not
TGF-β stimulation. Conversely, the TNF-α induced
expression of proMMP-9 was partially abolished by the
cells expressing the kinase-negative PAK1 variants. Similar
to the fibroblasts, the protein levels of the wild type PAK1
in the keratinocyte was clearly enhanced by TNF-α treat-
ment (Fig. 3B). Taken together, we demonstrated a novel
regulation of PAK1 by TNF-α, which is mediated by an
unknown mechanism to stabilize the PAK1 protein.
Expression of MMP-9, but not MMP-2, -3, -14, is 
specifically controlled by PAK1
The intriguing regulation of MMP-9 by PAK1 as shown in
Fig. 2A prompted us to examine regulation of other
MMPs. Dermal fibroblasts transduced by lentivirus
expressing GFP or inactive PAK1 (K299R) were embedded
in 3D type-I collagen. After 3 days of stimulation with
cytokines, the secreted MMP-3 in conditioned medium
was measured by Western blot analysis. As shown in Fig.Page 4 of 15
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BMC Immunology 2009, 10:15 http://www.biomedcentral.com/1471-2172/10/154A, TNF-α, but not TGF-β, induced MMP-3, while combi-
nation of the two cytokines promoted synergistic induc-
tion of MMP-3, in a manner very similar to MMP-9
expression. However, in a drastic contrast to MMP-9, the
cytokine-induced MMP-3 expression is not affected by
over expression of PAK1 variants. The mRNA levels of
MMP-2, -3, -9, -14, and TIMP-1 were measured by real-
time RT-PCR. As shown in Fig. 4B, after 16 hr stimulation
the mRNA of MMP-3 was induced 6 folds by TNF-α and
additionally enhanced by the combination with TGF-β,
which is closely correlated to MMP-3 protein expression.
The cytokine-mediated induction of these MMPs was not
altered by forcedly expressed PAK1. In a similar fashion,
the low level expression of the mRNA of MMP-2, -14, and
TIMP-1 was also not altered by PAK1. Again, PAK1 vari-
ants thoroughly suppressed the cytokine-exerted MMP-9
mRNA elevation. These results clearly demonstrate a spe-
cific mode of PAK1 in regulation of MMP-9 expression.
PAK1 mediates TNF-α-induced MMP-9 but not MMP-2Figure 2
PAK1 mediates TNF-α-induced MMP-9 but not MMP-2. (A) HDFs and the cells transduced by lentivrius expressing 
GFP or PAK1 variants (K299R, catalytic inactive) were cultured in 3D type-I collagen. After culture for 3 days with TNF-α at 
the indicated concentrations, the gelatinases in the conditioned medium were measured by zymography. (B) HDFs expressing 
GFP or a PAK1 variant were cultured on plastic or in 3D type-I collagen and treated by TNF-α or/and TGF-β for 16 hrs. The 
mRNA of MMP-9 was measured by real-time RT-PCR and normalized by GAPDH. The results are representative of three 
independent experiments. (C) The activities of 670-bp 5'-promoter of human MMP-9 were measured by transient transfection 
of HDFs expressing GFP or PAK1 mutant (K299R) with pGL2 reporter plasmids encoding firefly luciferase and CMV promoter 
driving renilla luciferase. The resultant cells were stimulated by cytokines for 16 hrs (n = 6). (D) HDFs ectopically expressed 
PAK1 protein were stimulated by TNF-α for 3 days. PAK1 protein was measured by Western blot analysis. Of note is the 
increased the viral promoter driven PAK1 protein in response to TNF-α. (E) HDFs expressing PAK1 were treated with or 
without TNF-α together with cycloheximide (20 μg/ml). At the indicated intervals the cells were harvested for Western blot 
analysis of PAK1.
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downstreamof PAK1 to promote MMP-9 expression
JNK signaling has been well defined as a key regulator to
initiate the transcription of many MMPs including MMP-
9 [20,21]. To probe the possible role of JNK in cytokine-
induced MMP-9 expression, we treated human dermal
fibroblasts in 3D type-I collagen or on plastic by inhibi-
tors for JNK (SP600125), p38 MAP kinase (SB239063),
and PI-3 kinase (wortmanin) at the effective concentra-
tion suggested by the manufacture. After 3 days of culture
with TNF-α and/or TGF-β, the conditioned medium was
examined for gelatinase activities. As shown in Fig. 5A, the
cytokine-induced MMP-9 was suppressed thoroughly by
the JNK inhibitor, although the inhibition efficacy was
slightly lower by the cells cultured in 3D gel, which may
be due to the adsorption or trap of the compound in the
scaffold of ECM. Expression of proMMP-2 (72-kDa) and
maturation to the active form (62-kDa) were clearly not
altered by the JNK inhibitor, indicating specific inhibition
and absence of general cellular toxicity. In contrast, the
inhibitors for p38MAP kinase and PI3 kinase were found
without effects on MMP-9 expression. Activation of JNK
by fibroblasts ectopically expressing PAK1 variants was
measured by antibody against p46 and p54 SAPK/JNK
dually phosphorylated at Thr183 and Tyr185 (Fig. 5B).
After 20 min treatment with cytokines JNK was phospho-
rylated in response to TNF-α by the controlled cells (GFP),
and largely abrogated by the cells expressing inactive
PAK1 (K299R) (Fig. 5C).
In addition to JNK and NF-κB pathways, TNF-α also acti-
vates p38MAP kinase, which prompted us to examine its
role in regulation of MMP-9 expression. Human dermal
fibroblasts transduced by lentivius expressing p38MAP
kinase or the dominant negative variant; and the resultant
cells were cultured either on plastic or in 3D gel followed
by treatment with cytokines. As shown in Fig. 6A,
cytokine-mediated proMMP-9 expression was not altered
by p38MAP kinase, which is in line with the results of the
inhibition experiment (Fig. 5A). In contrast, MMP-9, but
not MMP-2 expression, was totally suppressed by inactive
PAK1. Moreover, protein stability of the ectopically
expressed p38MAP kinase was not regulated by TNF-α
(Fig. 6B). Thus, JNK1 is likely to be a downstream effector
of PAK1 as demonstrated previously by others [22], and
we showed here such moiety in the TNF-α signaling to
control MMP-9 expression.
Not regulated by PAK1, NF- B signaling is essentialfor 
MMP-9 expression
Many studies have demonstrated the role of NF-κB in reg-
ulation of MMPs including MMP-9 by directly recruit-
ment of NF-κB to the cis-elements in the 5'-promoter of
MMP-9 [20,21]. Of interest is to know if NF-κB signaling
is also under control by PAK1. Activation of NF-κB was
measured by degradation of its inhibitor, IkappaB-α by
the fibroblasts under the context of GFP, PAK1 (K299R),
p38MAP kinase and its dominant negative variant. After
10 min of stimulation with TNF-α, IkappaB-α was
promptly up-shifted, presumably through hyper-phos-
phorylation (Fig. 7A). At 20 min after the challenge the
IkappaB-α was totally diminished by all these cells. Thus,
in contrast to JNK, NF-κB is independent of PAK1 signal-
ing. To confirm the notion of requirement of NF-κB we
treated the fibroblasts with inhibitor for IKK, and meas-
ured the mRNA and protein of MMP-9. As shown in Fig.
7B and 7C, the cytokine-induced expression of MMP-9 at
both mRNA and protein levels was partially suppressed by
the IKK inhibitor. Conversely, expression of MMP-2 was
not affected by the inhibitor. Thus, NF-κB signaling is
required, but not under control by PAK1, to induce MMP-
9 expression.
Phosphorylation, activation, and stabilization of 
endogenous PAK1 in response to TNF- /IL-1
Given the evidence of stabilization of the ectopically
expressed PAK1 by TNF-a signaling, and regulation of
MMP-9 expression by the kinase, an immediate question
is, therefore, to what extend the endogenous PAK1 is actu-
TNF-α-induced expression of MMP-9 through PAK1, and stabilization of the ectopically expressed kinase by humankerat nocytesFigure 3
TNF-α-induced expression of MMP-9 through PAK1, 
and stabilization of the ectopically expressed kinase 
by human keratinocytes. Immortalized human keratinoc-
ytes transduced by lentivrius expressing GFP or PAK1 vari-
ants were cultured in KGM. After culture for 3 days with 
cytokines the gelatinases in the conditioned medium were 
measured by zymography. (B) PAK1 and a non-specific pro-
tein as a negative control were measured by Western blot 
analysis.
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BMC Immunology 2009, 10:15 http://www.biomedcentral.com/1471-2172/10/15ally activated and stabilized in response to TNF-α. As
shown in Fig. 8A, the doublet bands of endogenous PAK1
were immediately elevated after 30 min treatment of
keratinocytes by TNF-α, and the PAK1 protein was sub-
stantially accumulated at 120 min. A band at 25 kDa, also
recognized by the antibodies for PAK1, a presumable deg-
radation product at basal state, was gradually diminished,
whereas the full length PAK1 accumulated after TNF-α
treatment, indicating a possible mechanism that TNF-α
suppresses the turnover of PAK1. As an internal control,
two bands at about 45-kDa were constitutively expressed
in a mode independent of TNF-α. As a general way to acti-
vate a protein kinase, a site within the pseudo-substrate
loop in the catalytic domain is phosphorylated in
MMP-9, but not other MMPs, is specifically regulated by PAK1Figure 4
MMP-9, but not other MMPs, is specifically regulated by PAK1. (A) HDFs transduced by lentivrus expressing GFP or 
PAK1 variant (K299R) were embedded in type-I collagen and treated by cytokines for 3 days. MMP-3 in the conditioned 
medium was measured by Western blot analysis. (B) After 16 hrs of treatment with cytokines, the mRNA of MMPs and TIMP-
1 were measured by real-time RT-PCR, normalized by GAPDH (n = 3).
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BMC Immunology 2009, 10:15 http://www.biomedcentral.com/1471-2172/10/15response to stimulation [23]. Phosphorylation of PAK1 at
threonine-423 has been demonstrated as an indicator for
activation state of the kinase [24]. In response to TNF-α,
phosphorylation of threonine-423, as measured by anti-
bodies for the phosphopeptide, promptly appeared at 10
min, and peaked at 20 min (Fig. 8B). PAK1 can also be
phosphorylated at threonine-212 presumably by Cdc2/
Cdk5 [25]. As shown in Fig. 8C, threonine-212 phospho-
rylation occurred maximally at 10 min after TNF-α stimu-
lation, prior to the threonine-423 phosphorylation.
We then fractioned cellular compartments, and found
that most of PAK1 protein and the threonine-212 phos-
phorylated version being present in cytosolic fractions
rather than in the membrane pools. Similarly, threonine-
423 of PAK1 was phosphorylated in dermal fibroblasts in
response to TNF-α stimulation but in the prompt manner
as in the keratinocytes (Fig. 8E). Importantly, fibroblasts
over expressing PAK1 variants failed to show threonine-
423 phosphorylation, which sufficiently explains its role
in the impairment of the signaling in MMP-9 expression
(Fig. 8E and 2). Similar to keratinocytes, dermal fibrob-
lasts expressing GFP showed prompt phosphorylation of
threonine-212 in response to TNF-α (Fig. 8F). We were
interested to know whether PAK1 can be activated by IL-
1, which shares many signaling pathways with TNF-α.
JNK, as a downstream effector of PAK1, is essential for MMP-9 but not MMP-2 expressionFigure 5
JNK, as a downstream effector of PAK1, is essential for MMP-9 but not MMP-2 expression. (A) Normal HDFs, cul-
tured on plastic or in 3D type-I collagen, were treated by cytokines together with inhibitors for p38 MAP kinase, JNK, and PI-
3' kinase respectively at their effective concentrations. MMP-9 and -2 in the conditioned medium were detected by zymogra-
phy. (B) HDFs transduced by lentivirus expressing GFP or PAK1 variant (K299R) were stimulated by cytokines for 20 min. 
JNK1/2 and the phosphorylated JNK were measured by Western blot analysis. (C) The levels of phosphorylated JNK1/2 were 
quantitated by densitometry analysis, and normalized by their protein levels. Data are the averages of three experiments.
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BMC Immunology 2009, 10:15 http://www.biomedcentral.com/1471-2172/10/15Our previous work showed that the hepatic stellate cells
can vigorously produce both proMMP-9 and the mature
proteinase in response to IL-1 stimulation only by the
cells cultured in type-I collagen [7,26]. As expected, in the
rat hepatic stellate cells, PAK1 underwent phosphoryla-
tion at threorine-212 (10 min), followed by phosphoryla-
tion at threorine-423 (30 min) (Fig. 9). Taken together,
through analysis of these three cell types we found that
under TNF-α stimulation PAK1 is phosphorylated in a
dynamics starting at threonine-212 followed by threo-
nine-423 phophorylation, which confers the kinase to an
active state. Given the fact of failed activation of PAK1 by
the variants, and the evidence of their equal stabilization
by these PAK1 variants, the TNF-α induced stabilization
of PAK1 is, therefore, very likely independent of the
kinase activation mechanism.
Contribution of collagen to TNF- -induced MMP-9 
expression by fibroblasts is associated with persistent 
activation ofJNK
It still remains outstanding how ECM boosts the TNF-α
signaling to induce MMPs by the mesenchymal cells in tis-
sue environment, as shown in Fig. 1. First, we examined
whether collagen can boost the JNK signaling, for the rea-
son, in part, of its role in MMP-9 regulation, and under
the PAK1 signaling. Our previous work also demonstrated
additive stimulation of the minimal promoter of human
MMP-9 by collagen and TNF-α, while the convergences
between the TNF-α and collagen signals are not known
[6]. Thus far, we examined the influence of collagen on
the kinetics of JNK activation by human dermal fibrob-
lasts. Cells were cultured on plastic or in type-I collagen to
measure the strength and speed of the response. As shown
in Fig. 10, phosphorylation of both JNK1 and JNK2
promptly occurred at 5 min after TNF-α challenge,
reached to peaks at 15 min, and followed by gradual
decline. Although collagen alone could not trigger JNK
activation, it did magnify the amplitude of JNK1/2 phos-
phorylation. Densitometry scanning revealed a two-fold
enhancement of phospho-JNK1/2 by the cells cultured in
type-I collagen. Therefore, the synergistic effect of collagen
to cooperate with TNF-α in induction of MMP-9 can be
explained, at least in part, by the amplification of JNK
activities.
Discussion
Expressed in early embryonic development, MMP-9 is
largely silent in many adult tissues; while MMP-2, another
member of the gelatinase family, is constitutively
expressed in health tissues. However, upon injury such as
mechanical trauma, thermal burn, and viral infection,
MMP-9 is promptly elevated, indicating its role in wound
healing by activating the stromal cells, releasing growth
factors, and initiating cell migration. On the other hand,
persistent presence of large amount of MMPs is often asso-
ciated with, if not results in, many inflammatory diseases
such as chronic wounds, arthritis, and cancer metastasis.
Despite large body of efforts to discover the intracellular
signal pathways to control MMPs in variety of cells, little
is known as to how ECM in cooperating with the cytokine
signals regulates MMP expression, particularly by the mes-
enchymal cells. In ECM scaffolds the mesenchymal cells
are intensified by the intracellular cytoskeletal networks
which are essential for cell anchoring, migration, and pro-
liferation in the waves of cytokines during wound healing
processes. Organization of intracellular cytoskeletal
framework is largely orchestrated by small GTPases and
their down stream effectors. To these regards, we investi-
gated the role of PAK1 in regulation of MMPs by three cell
types from msenchymal to epithelial cells. In summary,
we have found (1) TNF-α triggers a sequential phosphor-
ylation events in PAK1, starting at threonine-212 followed
by threonine-423, which may confers the kinase into
active state; (2) TNF-α promptly elevates PAK1 protein
level, presumably through stabilization, which is inde-
pendent on the kinase activity and p21 GTPase binding
capacity; (3) TNF-α induced expression of MMP-9 is
mediated by PAK1/JNK pathway which controls transcrip-
tional initiation of MMP-9 promoter.
Originally identified as targets by GTP-loaded p21 pro-
tein, PAK family with 6 members has been demonstrated
to serve as important regulators in cytoskeletal dynamic
and cell motility, presumably through phosphorylation of
p38 MAP kinase is not required for MMP-9 expression and stability of the kinase is not gulated by TNF-αFigure 6
p38 MAP kinase is not required for MMP-9 expres-
sion and stability of the kinase is not regulated by 
TNF-α. (A) HDFs transduced by lentivirus expressing GFP, 
PAK1 (K299R), p38 MAP kinase, and its dominant negative 
one were cultured on plastic or in 3D type-I collagen, fol-
lowed by stimulation by cytokines. After 3 days, MMP-9 and -
2 in the conditioned medium were measured by zymography. 
(B) Protein of p38MAP kinase was measured by Western 
blot analysis.
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BMC Immunology 2009, 10:15 http://www.biomedcentral.com/1471-2172/10/15the downstream substrates such as Lim kinase and myosin
light chain kinase [12]. Like many protein kinases, PAK1
activity is restrained in latency by formation of
homodimer through the interaction between the kinase
inhibitory domain and the catalytic activation loop,
which prevents the kinase from access the substrates [27].
The first step to provoke activation of PAK1 is believed to
disrupt such trans-inhibition interaction, which can be
conducted by variant ways such as binding of p21 GTPase,
partial cleavage by caspase, association with sphingolip-
ids, and phosphorylation [28]. The second step is to main-
tain the "opened" status by auto-phosphorylation at
theronine-423 of the active loop in catalytic domain
[29,30]. On the other hand, it is unknown whether
inflammatory cytokines regulate PAKs, and how such reg-
ulation controls MMP in inflammation process.
In this study we first assessed the contribution of dermal
fibroblasts and keratinocytes to the massive expression of
MMP-9 by non-healing skin tissues. Although both der-
mal fibroblasts and keratinocytes produce MMP-9 in
response to TNF-α/IL-1, dermal fibroblasts require type-I
collagen as additional factor to maximally induce the pro-
teinase, which makes pathophysiological sense as a para-
digm between an enzyme and its substrate in a mutual
demanding in order to maintain tissue homeostasis (Fig.
1). Still unknown is how TGF-β in concert with TNF-α
enhances MMP-9 expression by fibroblasts of human and
rodent skin, while TGF-β alone is not sufficient to induce
the proteinase [6]. According to present results, TGF-β is
unable to cooperate with TNF-α to activate JNK or NF-κB
pathway (Fig. 5B and data not shown). However, the mag-
nified activation of JNK by the dermal fibroblasts cultured
on type-I collagen as shown in Fig. 10 may explain, at least
in part, the role of TGF-β through the capacious capacity
to induce of type-I collagen (data not shown). The role of
TGF-β is surely cell-type specific and depends on the con-
text of other signaling, as we found TGF-β suppresses the
IL-1-induced expression of MMPs by hepatic stellate cells
[7,26].
NF-κB pathway is required for MMP-9 expression, but is independent of PAK1 and p38 MAP kinaseFigure 7
NF-κB pathway is required for MMP-9 expression, but is independent of PAK1 and p38 MAP kinase. (A) HDFs 
transduced by lentivrius expressing GFP, PAK1 (K299R), p38 MAP kinase, and its dominant negative ones were cultured on 
plastic and treated by TNF-α for the indicated intervals. Degradation of I-kappaB was measured by Western blot analysis. (B) 
HDFs were treated by TNF-α with IKK inhibitors at the indicated concentration for 6 hrs. The mRNA of MMP-9 was meas-
ured by real-time RT-PCR analysis. Results are from the average of three experiments. (C) HDFs were treated by TNF-α with 
IKK inhibitors at low concentration for 3 days. MMP-9 and -2 were measured by zymography.
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BMC Immunology 2009, 10:15 http://www.biomedcentral.com/1471-2172/10/15Still intriguing is how MMP-9, but not MMP-3, is specifi-
cally subjected to PAK1 control under the same TNF-α
treatment (Fig. 2 and 4). The suppression of MMP-9
expression by PAK1 can be attributed, in part, to the tran-
scription activation, since the ectopically expressed PAK1
mutant impairs the proximal 5'-promoter activities of
MMP-9, and completely suppresses the accumulation of
the mRNA and protein of MMP-9. Such suppression is in
line with the impaired activation of JNK, but not NF-κB
(Fig. 5 and 8). This notion is further reinforced by our
inhibition experiment, by which JNK inhibitor thor-
oughly disrupts expression of MMP-9 (Fig. 5). Clues of
PAK1 in regulates MAP kinase come from the work on
yeast mating as well as reconstitution experiments
[16,17,31,32]. In addition to JNK, PAK1 has been shown
to induce activation of p38 MAP kinase pathways [33,34].
In our study, neither expression of p38 MAP kinase vari-
ants nor inhibition with specific inhibitor for the kinase
does affect the MMP-9 at all (Fig. 4 and 7).
It is unknown, to date, how TNF-α promotes activation of
PAK1 protein [35]. Phosphorylation of thronine-423 in
the active loop has been demonstrated as an indicator for
activation of PAK1 [15,24]. In addition to p21 GTPase
binding and thereafter induced auto-phosphorylation of
PAK1, PDK was also found to phosphorylate thronine-
Activation and stabilization of endogenous PAK1 in response to TNF-α by keratinocytes and dermal fibroblastFigure 8
Activation and stabilization of endogenous PAK1 in response to TNF-α by keratinocytes and dermal fibroblast. 
(A) Keratinocytes (IKCs) were treated by TNF-α for the indicated periods and PAK1 protein was measured by Western blot 
analysis. Intact PAK1 and the putative degradation and non-specific bands were indicated. (B) Threonine-423 phosphorylation 
of PAK1 by the IKCs in response to TNF-α was measured by Western blot analysis. (C) Threonine-212 phosphorylation of 
PAK1 by the IKCs in response to TNF-α was measured by WB analysis. (D) Distribution of phosphorylated PAK1 in cytosolic 
and membrane compartments was measured by Western blot analysis. GAPDH was used as an indicator for cytosolic proteins. 
(E) Threonine-423 phosphorylation of PAK1 by HDFs was measured by Western blot analysis. (F) Thronine-212 phosphoryla-
tion by HDFs was measured by WB analysis.
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BMC Immunology 2009, 10:15 http://www.biomedcentral.com/1471-2172/10/15423 of PAK1 [15]. In this study we found TNF-α exerts
sequential phosphorylation of PAK1, started at thronine-
212 (10-min) and followed by thronine-423 phosphor-
ylation (20-min). Following PAK1 activation is the accu-
mulation of the protein of the kinase per se. We
concluded that TNF-α induced accumulation of PAK1 is
regulated at post-transcriptional level. Such conclusion is
based on the following evidences: (1) Cycloheximide,
which suppresses protein synthesis in general, does not
affect PAK1 protein under TNF-α stimulation; (2) The
constitutively expressed PAK1 under viral promoter is also
up regulated by TNF-α, and as a control the p38 MAP
kinase is not altered at all, which strongly supports the
mechanism of protein stabilization; (3) Up regulation of
PAK1 by TNF-α or IL-1 seems ubiquitous, since it is
detected by human dermal fibroblasts, and keratinocytes,
as well as rat hepatic stellate cells; (4) TNF-α induced
accumulation of 66-kDa PAK1 is inversely correlated with
the loss of the degradation band at 25-kDa (Fig. 8A). All
these indicate that TNF-α may somehow attenuate the
degradation of PAK1 protein. Clearly, the TNF-α induced
stabilization of PAK1 is independent of its intrinsic kinase
and p21 GTPase-binding capacity. Most of PAK1 is com-
partmented in cytosolic pool, of which is promptly
induced by TNF-α; while the kinase in the membrane frac-
tions is not regulated (data not shown). To date, it is
unknown how TNF-α regulates PAK1 stability.
Conclusion
We identified a novel mechanism of MMP-9 expression
controlled by TNF-α through stabilization and activation
of PAK1 which in turn activates JNK pathway leading the
transcription of MMP-9.
Methods
Materials and reagents
Cytokines were purchased from R&D Systems. Antibodies
against PAK1, p38 MAP kinase, I-kappaB, MMP-3 and
MMP-9 were purchased from Santa Cruz Biotechnologies.
Antibodies for JNK, phospho-JNK (Phospho-SAPK/JNK
(Thr183/Tyr185), phospho-PAK1 (Thr423)/PAK2
(Thr402) were from Cell Signaling Technology. Antibod-
ies for phosphor-212-threonine-PAK1 were from Sigma.
Antibodies for GAPDH were from Chemicon. SuperSignal
West Fermto Maximum Sensitivity Substrate was from
PIERCE. The 5'-670 bp promoter of human MMP-9 was
cloned into plasmid pGL2/firefly luciferase (pGL-5'670-
MMP9). The Dual-Luciferase® Reporter (DLR) Assay Sys-
tem was from Promega. Lentivirus encoding PAK1 vari-
ants including wild type, triple mutant (H83L, H86L and
K299R) and K299R were kindly provided by G. Bokoch
(The Scripps Research Institute, La Jolla, CA). Colla-
genase, inhibitors for IKK (#401486), JNK inhibitors
(SP600125), and p38 MAP kinases (SB 239063) were
from Calbiochem.
Biopsies
Clinical biopsies including normal skin and chronic
wounds were collected according to the protocol
approved by Internal Review Board at the University of
Southern California and are consent by patients. The 6-
mm punch biopsies were placed in 2-ml DMEM with anti-
biotics (200 U/ml penicillin G sodium, 200 U/ml strepto-
mycin sulfate and 0.5 μg/ml amphotericin B). To
accumulate secreted factors the biopsies were incubated in
the medium for 6 hours with supply of 5% CO2 at 37°C.
The conditioned medium was cleared of debris by centrif-
ugation at 5,000 g prior to zymography or Western blot
analysis.
Cell culture, lentiviral transduction, and luciferase assay
To isolate human dermal fibroblasts, full thickness skin
was treated by 20 mM EDTA in DMEM at 37°C for 3 hrs.
After removal of epithelial sheets the dermal tissue was
incubated in collagenase (2 mg/ml) in DMEM at 37°C for
16 hrs. The resultant cells were seeded on dishes and cul-
tured in DMEM with 10% FBS. The second passage of cells
was used for experiments. Immortalized human keratino-
cytes were kindly provided by Dr. David Woodley at USC.
Primary rat hepatic stellate cells were supplied from the
USC Research Center for Alcoholic and Pancreatic Dis-
eases, and cultured in DMEM with 10% FBS. Kratinocytes
and human dermal fibroblasts were transduced by lentivi-
rus prepared in 293T cells. To ensure the high transducing
efficiency the cells were infected twice. Efficiency of trans-
duction was measured by immunostaining with anti-
IL-1 stimulation of PAK1 phosphorylation by primary rat hepatic stellate cellsFigure 9
IL-1 stimulation of PAK1 phosphorylation by primary 
rat hepatic stellate cells. Primary rat hepatic stellate cells 
were stimulated by IL-1α for the indicated time. Phosphor-
ylation of PAK1 at threonine 423 and threonine-212 and 
GAPDH were measured by Western blot analysis.
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BMC Immunology 2009, 10:15 http://www.biomedcentral.com/1471-2172/10/15PAK1 as well by expression of green fluorescent protein as
an indicator. To create 3-dimensional culture, fibroblasts
were embedded in type-I collagen as previously described
[6]. To measure the promoter activities the dermal fibro-
balsts were transfected by a reporter plasmid together with
pGL/CMV-renilla luciferase as a reference. Luciferase
activities were measured by the dual luciferase assay kit.
Cell treatment and real-time RT-PCR
Cells on plastic or 3D ECM were treated with TNF-α (10
ng/ml), IL-1α (10 ng/ml), TGF-β1 (1 ng/ml) in DMEM
with 1% FBS for 16 hrs. Total RNA was extracted using
TRIZOL reagent according to the manufacturer's instruc-
tions (Invitrogen Life Technologies). First-strand cDNA
was produced using First-Strand cDNA Synthesis by
SuperScript II Reverse Transcriptase with random primers.
Two micrograms of total RNA was used for each reverse
transcription reaction mixture (20 μl). Real-time PCR was
carried out using an ABI Prism 7900 HT (Applied Biosys-
tems). 10 μl reactions were set up in 384-well PCR plate
using the following final concentrations: 1 μmole each of
forward and reverse primers, 1× SYBR Green master mix
(qPCR Mastermix Plus for SYBR Green I, Eurogentec), and
5 ng of cDNA. For each condition three duplicates were
used to minimize the variation. Cycling conditions were
as follows: initial step (50°C for 2 min), hot activation
(95°C for 10 min), amplification (95°C for 15 s, 60°C for
1 min) repeated 40 times, and quantification with a single
fluorescence measurement. Data were analyzed using ABI
Prism SDS 2.1 software. The relative gene expression was
calculated by the ΔCt method. Briefly, the resultant mRNA
was normalized to its own GAPDH. Final results were
expressed as n-fold difference in gene expression relative
to GAPDH mRNA and calibrator as follows: n-fold = 2-(ΔCt
Type-I collagen enhances TNF-α induced activation of JNK by dermal fibroblastsFigure 10
Type-I collagen enhances TNF-α induced activation of JNK by dermal fibroblasts. (A) HDFs were cultured on plas-
tic or type-I collagen and stimulated by TNF-α for the indicted intervals. Phospho-JNK and JNK proteins were measured by 
Western blot analysis. (B) Activation of JNK was quantitated by densitometry analysis and plotted by the ratio of phosphor-
JNK vs. JNK protein as arbitrary units.
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BMC Immunology 2009, 10:15 http://www.biomedcentral.com/1471-2172/10/15sample-ΔCt GAPDH), where ΔCt values of the sample and the
calibrator were determined by subtracting the average Ct
value of the transcript under investigation from the aver-
age Ct value of the GAPDH gene for each sample. For
human MMP-9 the forward primer has the sequence GGG
AGA CGC CCA TTT CG and the reverse primer is CGC
GCC ATC TGC GTT T. For GAPDH, the forward primer,
GAA GGT GAA GGT CGG AGT 3', and backward primer
GAA GAT GGT GAT GGG ATT TC 3' 20 mer. For MMP-14,
the primers are TGG AGG AGA CAC CCA CTT TGA, and
GCC ACC AGG AAG ATG TCA TTT C. For MMP-2, the
primers are GAG AAC CAA AGT CTG AAG AG, and GGA
GTG AGA ATG CTG ATT AG. For MMP-3, the primers are
GCT GCA AGG GGT GAG GAC AC, and GAT GCC AGG
AAA GGT TCT GAA GTG. The primers for TIMP-1 are TCT
GGC ATC CTC TTG TTG CTA T, and CCA CAG CGT CGA
ATC CTT.
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